We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Reverses, Says ‘Vimovo’ Patents Insufficiently Descriptive

Mealey's (May 16, 2019, 1:07 PM EDT) -- WASHINGTON, D.C. — A New Jersey federal judge’s finding that two patents covering the pain-reliever drug “Vimovo” are adequately described under Section 112 of the Patent Act, 35 U.S.C. § 112,...
To view the full article, register now.